Texas Sues Tylenol Maker Over Allegedly Omitting Evidence Of Autism Link From Marketing

A lawsuit filed by Texas Attorney General Ken Paxton alleges that Tylenol's manufacturers intentionally concealed evidence linking the drug to autism. Paxton claims that scientific studies, including one in JAMA Psychiatry, indicated a higher risk of autism spectrum disorder and ADHD in children whose mothers took acetaminophen during pregnancy. The lawsuit states that Johnson & Johnson, the former manufacturer, promoted Tylenol as safe for pregnant women, even directing them to a website it owned. Johnson & Johnson spun off its manufacturing unit into Kenvue in 2022, a move Paxton argues was intended to evade liability. Despite internal concerns from a Johnson & Johnson scientist about mounting evidence, the company did not warn consumers. The current Tylenol label lacks autism or ADHD warnings, though federal officials are reportedly updating labels and acknowledging a potential link. Kenvue maintains the safety of acetaminophen and plans to vigorously defend against the claims, advising pregnant women to consult healthcare professionals. Paxton seeks to stop deceptive Tylenol advertising in Texas and fine the companies for violations. He accuses "Big Pharma" of knowingly endangering millions for profit and attempting to shirk responsibility.